Effects of health insurance and race on early detection of cancer

Journal of the National Cancer Institute

Volumn 91, Issue 16, 1999, Pages 1409-1415

  Roetzheim, Richard G ^c   Pal, Naazneen ^d   Tennant, Colleen ^d   Voti, Lydia ^d   Ayanian, John Z ^a   Schwabe, Annette ^b   Krischer, Jeffrey P ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b FLORIDA DEPARTMENT OF HEALTH   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER STAGING; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; EARLY DIAGNOSIS; EDUCATION; FEMALE; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAID; MELANOMA; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; SEX DIFFERENCE; UNITED STATES;

EID: 0033581147     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.16.1409     Document Type: Article

References (73)

1. Kosary CL, Ries LA, Miller BA, Hankey BF, Harras A, Edwards BK. SEER cancer statistics review, 1973-1992: tables and graphs. Bethesda (MD): National Cancer Institute; 1995.
2. Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst 1993;85:1129-37.
3. Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 1994;272:947-54.
4. Jones BA, Kasl SV, Curnen MG, Owens PH, Dubrow R. Can mammography screening explain the race difference in stage at diagnosis of breast cancer? Cancer 1995;75:2103-13.
5. Gordon NH, Crowe JP, Brumberg DJ, Berger NA. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 1992;135:609-18.
6. Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. Impact of access and social context on breast cancer stage at diagnosis. J Health Care Poor Underserved 1995;6:342-51.
7. Coates RJ, Bransfield DD, Wesley M, Hankey B, Eley JW, Greenberg RS, et al. Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group. J Natl Cancer Inst 1992;84: 938-50.
8. Perkins P, Cooksley CD, Cox JD. Breast cancer. Is ethnicity an independent prognostic factor for survival? Cancer 1996:78:1241-7.
9. Bassett MT, Krieger N. Social class and black-white differences in breast cancer survival. Am J Public Health 1986;76:1400-3.
10. Richardson JL, Langholz B, Bernstein L, Burciaga L, Danley K, Ross RK. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 1992; 65:922-6.
11. Farley TA, Flannery JT. Late-stage diagnosis of breast cancer in women of lower socioeconomic status: public health implications. Am J Public Health 1989;79:1508-12.
12. Wells BL, Horm JW. Stage at diagnosis in breast cancer: race and socioeconomic factors. Am J Public Health 1992;82:1383-5.
13. Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type [published erratum appears in Am J Public Health 1991;81:980]. Am J Public Health 1991 ;81: 646-9.
14. Nayeri K, Pitaro G, Feldman JG. Marital status and stage at diagnosis in cancer. N Y State J Med 1992;92:8-11.
15. Moritz DJ, Satariano WA. Factors predicting stage of breast cancer at diagnosis in middle aged and elderly women: the role of living arrangements. J Clin Epidemiol 1993;46:443-54.
16. Riley GF, Potosky AL, Lubitz JD, Brown ML. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health 1994:84:1598-604.
17. Potosky AL, Merrill RM, Riley GF, Taplin SH, Barlow W, Fireman BH, et al. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst 1997;89:1683-91.
18. Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 1993:329:326-31.
19. Osteen RT, Winchester DP, Hussey DH, Clive RE, Friedman MA, Cady B, et al. Insurance coverage of patients with breast cancer in the 1991 Commission on Cancer Patient Care Evaluation Study. Ann Surg Oncol 1994;1: 462-7.
20. Blustein J. Medicare coverage, supplemental insurance, and the use of mammography by older women. N Engl J Med 1995;332: 1138-43.
21. Breast and cervical cancer screening among underserved women. Baseline survey results from six states. The National Cancer Institute Cancer Screening Consortium for Underserved Women. Arch Fam Med 1995:4:617-24.
22. Hayward RA, Shapiro MF, Freeman HE, Corey CR. Who gets screened for cervical and breast cancer? Results from a new national survey. Arch Intern Med 1988;148:1177-81.
23. Kirkman-Liff B, Kronenfeld JJ. Access to cancer screening services for women. Am J Public Health 1992;82:733-5.
24. Kaplan RM, Navarro AM, Castro FG, Elder JP, Mishra SI, Hubbell A, et al. Increased use of mammography among Hispanic women: baseline results from the NCI Cooperative Group on Cancer Prevention in Hispanic Communities. Am J Prev Med 1996;12: 467-71.
25. Schroeder SA. The medically uninsured - will they always be with us? N Engl J Med 1996; 334:1130-3.
26. Valdini A, Cargill LC. Access and barriers to mammography in New England community health centers. J Fam Pract 1997;45:243-9.
27. Woolhandler S, Himmelstein DV. Reverse targeting of preventive care due to lack of health insurance. JAMA 1988;259:2872-4.
28. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol 1994;151: 1283-90.
29. Mettlin CJ, Murphy GP, McGinnis LS, Menck HR. The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1995;76:1104-12.
30. Mettlin C, Murphy GP, Babaian RJ, Chesley A, Kane RA, Littrup PJ, et al. The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer 1996;77:150-9.
31. Morrison AS. Review of evidence on the early detection and treatment of breast cancer. Cancer 1989;64(12 Suppl):2651-6.
32. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer - The Health Insurance Plan project and its sequelae, 1963-1986. Baltimore (MD): Johns Hopkins University Press; 1988.
33. Newcomb PA, Norlfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
34. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
35. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996;88:17-23.
36. Roush GC, Berwick M, Koh HK, MacKie R. Screening for melanoma. Philadelphia (PA): JB Lippincott; 1992.
37. Hofer TP, Wolfe RA, Tedeschi PJ, McMahon LF, Griffith JR. Use of community versus individual socioeconomic data predicting variation in hospital use. Health Serv Res 1998;33: 243-59.
38. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;87:703-10.
39. Krieger N, Fee E. Social class: the missing link in U.S. health data. Int J Health Serv 1994;24: 25-44.
40. Diez-Roux AV. Bringing context back into epidemiology: variables and fallacies in multilevel analysis. Am J Public Health 1998;88: 216-22.
41. Shambaugh EM, Weiss MA. Summary staging guide: cancer Surveillance, Epidemiology, and End Results reporting. Bethesda (MD): National Institutes of Health; 1977.
42. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-83.
43. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
44. th revision, clinical modification. Washington (DC): Public Health Service, US Department of Health and Human Services; 1980.
45. Hosmer DW, Lemeshow S. Applied logistic regression. New York (NY): John Wiley & Sons; 1989.
46. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-9.
47. Cancer facts and figures. Atlanta (GA): American Cancer Society; 1998.
48. Screening mammography: a missed clinical opportunity? Results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey Studies. JAMA 1990;264: 54-8.
49. Blendon RJ, Benson JM. Whatever happened to politicians' concerns about the nation's uninsured? [editorial]. Am J Public Health 1998; 88:345-6.
50. Carrasquillo O, Himmelstein DU, Woolhandler S, Bor DH. Can Medicaid managed care provide continuity of care to new Medicaid enrollees? An analysis of tenure on Medicaid. Am J Public Health 1998;88:464-6.
51. Kulkarni PR, Vernon SW, Jackson GL, Lairson D, Davis BR. Stage at diagnosis of breast cancer. Comparison in a fee-for-service and health maintenance organization practice. Med Care 1989;27:608-22.
52. Greenwald HP. HMO membership, copayment, and initiation of care for cancer: a study of working adults. Am J Public Health 1987; 77:461-6.
53. Greenwald HP, Henke CJ. HMO membership, treatment, and mortality risk among prostatic cancer patients. Am J Public Health 1992;82: 1099-104.
54. Francis AM, Polissar L, Lorenz AB. Care of patients with colorectal cancer. A comparison of a health maintenance organization and feefor-service practices. Med Care 1984;22: 418-29.
55. Retchin SM, Brown B. Management of colorectal cancer in Medicare health maintenance organizations. J Gen Intern Med 1990;5:110-4.
56. Vernon SW, Hughes JI, Heckel VM, Jackson GL. Quality of care for colorectal cancer in a fee-for-service and health maintenance organization practice [published erratum appears in Cancer 1994:74:3249]. Cancer 1992;69: 2418-25.
57. Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA 1999;281:720-6.
58. Kuttner R. Must good HMOs go bad? First of two parts: the commercialization of prepaid group health care. N Engl J Med 1998;338: 1558-63.
59. Kuttner R. Must good HMOs go bad? Second of two parts: the search for checks and balances. N Engl J Med 1998;338:1635-9.
60. Retchin SM. Heterogeneity of health maintenance organizations and quality of care. J Natl Cancer Inst 1997;89:1654-5.
61. Hollman L, Nohlgren S. Founder of IMC indicted. In: St. Petersburg Times. St. Petersburg (FL); April 23, 1987. p. 1A.
62. Gentry C, Nickens T. More problems for IMC: Medicare cancels contract. In: St. Petersburg Times. St. Petersburg (FL); May 2, 1987. p. 1A.
63. State vows reform of Medicaid HMOs. In: Sun-Sentinel. Ft. Lauderdale (FL); December 2, 1995.
64. Dismantle failing Medicaid HMOs, congressman says. In: Sun-Sentinel. Ft. Lauderdale (FL); December 22, 1994.
65. Leider PJ, Solberg R, Nesbitt T. Family physician perception of economic incentives for the provision of office procedures. Fam Med 1997;29:318-20.
66. McCarthy BD, Yood MU, MacWilliam CH, Lee MJ. Screening mammography use: the importance of a population perspective. Am J Prev Med 1996;12:91-5.
67. Burns RB, McCarthy EP, Freund KM, Marwill SL, Shwartz M, Ash A, et al. Black women receive less mammography even with similar use of primary care. Ann Intern Med 1996;125: 173-82.
68. Chang SW, Kerlikowske K, Napoles-Springer A, Posner SF, Sickles EA, Perez-Stable EJ. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer 1996;78:1395-402.
69. Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 1998;279:1801-7.
70. Cooper GS, Yuan Z, Landefeld CS, Rimm AA. Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health 1996;86: 582-6.
71. Robbins AS, Whittemore AS, Van Den Eeden SK. Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst 1998;90:986-90.
72. Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst 1996;88:1031-8.
73. Morgan RO, Virnig BA, DeVito CA, Persily NA. The Medicare-HMO revolving door - the healthy go in and the sick go out. N Engl J Med 1997;337:169-75.